Interestingly, rIL-22 administration prior to infection tended to decrease MIP-2 expression in the lungs of infected mice compared with PBS-treated mice (p = 0.17) in contrast with IL-22 neutralisation which led to an increase of CXCL2 expression (Fig. 5f). Here, CXCL2 is linked to infection.